申请人:Jimenenz Hermogenes N.
公开号:US20100022546A1
公开(公告)日:2010-01-28
The present invention provides adamantyl-diamide derivatives of formula (1):
wherein R
1
and R
2
are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
本发明提供了公式(1)的脱氢胆酸二酰胺衍生物:其中R1和R2如本文所定义,或其药用可接受的盐;以及使用相同的药物组合物和方法。